University of Houston
uh.eduTotal trials
102
Active
17
Phase 3
0
Total enrollment
14,500
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Nicotine replacement therapy | — | — | — | — | — | 1 |
Next readouts
- 2027-08-31
Top conditions
- Anxiety6
- Smoking5
- Anxiety Disorders5
- Obesity5
- Stroke5
- Myopia4
- Smoking Cessation4
- Smoking, Tobacco4
Frequently asked questions about University of Houston
- How many clinical trials does University of Houston have on ClinicalTrials.gov?
- University of Houston is listed as the lead sponsor on 102 clinical trials in ClinicalTrials.gov, 17 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Houston's trials are in Phase 3?
- 0 of University of Houston's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University of Houston focus on?
- University of Houston's most-studied conditions on ClinicalTrials.gov are Anxiety, Smoking, Anxiety Disorders, Obesity, Stroke.
- When are University of Houston's next clinical trial readouts?
- University of Houston has 1 upcoming primary-completion readout tracked here; the soonest is “Smart Olfaction App to Reduce Relapse”, expected around 2027-08-31.